The Lowy Medical Research Institute is advised by a distinguished Board of Scientific Governors. Members of the Board are leaders in medicine, translational research, and basic science research. The Board advises on current scientific projects and future research directions at The Lowy Medical Research Institute.
Alan Bird, MD
Professor Emeritus, The Institute of Ophthalmology Moorfields Eye Hospital, London
Dr. Bird is Professor Emeritus; a distinguished clinician and scientist. Throughout his career, he has made significant contributions to vision research. His research has improved the understanding of retinal degenerative diseases, and the clinical management of those diseases.
Connie Cepko, Ph.D.
Bullard Professor of Genetics & Neuroscience, Harvard Medical School;
Investigator, Howard Hughes Medical Institute
Dr. Cepko is member of the Departments of Genetics and Ophthalmology at Harvard Medical School. She is also a Co-Director and founder of the Leder Human Biology and Translational Medicine training program at Harvard University. Her research focuses on identifying the molecular events that control retinal cell fate during development and cell death during disease.
John Dowling, Ph.D.
Gordon and Llura Gund Research Professor of Neurosciences, Harvard University
Dr. Dowling is a Professor at Harvard University, and an expert on retinal structure and function. His research interests have focused on neuronal organization in the retina, along with neurotransmission and neuromodulation.
Martin Friedlander, M.D., Ph.D
President of The Lowy Medical Research Institute;
Professor, Department of Cell and Molecular Biology, The Scripps Research Institute;
Chief, Retina Services, Department of Ophthalmology, Scripps Clinic
Dr. Friedlander is the President of LMRI, Professor at TSRI, and Chief of Retina Services at the Scripps Clinic. He oversees a laboratory program that is focused on understanding basic mechanisms that regulate the growth of new blood vessels as well as cell-cell interactions that help maintain normal neuronal function in the retina. His laboratory is interested in “translational” research with the goal of identifying new therapies to treat retinal diseases, including Macular Telangiectasia type 2.
Joseph G. Gleeson, M.D.
Rady Endowed Professor of Neuroscience, University of California, San Diego
Hess Professor, Laboratory for Pedatric Brain Diseases, Rockefeller University
Investigator, Howard Hughes Medical Institute
Dr. Gleeson is Professor of Neurosciences and Pediatrics at UCSD, Investigator with the Howard Hughes Medical Institute. His goal is to understand the genetic basis of diseases such as mental retardation, epilepsy and autism and develop new treatments. Dr. Gleeson is a member of the Institute of Medicine, a division of the National Academies of Science, Engineering and Medicine.
Robert Graham, A.O., F.A.A., M.D.
Executive Director, Victor Chang Cardiac Research Institute (VCCRI);
Sydney Des Renford Professor of Medicine, University of New South Wales
Dr. Graham is the Executive Director of the Victor Chang Cardiac Research Institute and a Professor of Medicine, Cardiology. He is a fellow of the Australian Academy of Science and a foreign member of the Royal Danish Academy of Sciences and Letters. He is a scientific advisor for a number of international research councils and boards.
Edward W. Holmes, M.D.
CEO/President of Sanford Consortium for Regenerative Medicine
Distinguished Professor, University of California
Vice Chancellor/Dean Emeritus of Health Sciences, UCSD
Executive Deputy Chairman, Biomedical Research Council, Singapore
Dr. Holmes was appointed a Howard Hughes Medical Investigator at Duke University School of Medicine in 1974 and later became the James B. Wyngaarden Professor of Medicine. He was recruited to the University of Pennsylvania School of Medicine in 1991 as the Chair of the Department of Medicine and the Frank Wister Thomas Professor of Medicine and Genetics.
Ehud Isacoff, PH.D.
Chair and Professor of Neurobiology, University of California, Berkeley
Dr. Isacoff is a Professor at UC Berkeley, in the Department of Neuroscience. He has been a pioneer of optogenetics research, using light to study neural circuits and neural transmission. He applies this research to neuronal diseases, including retinal disease, to restore neural function.
Susan Quaggin, M.D., F.R.C.P.(C)
Professor, Northwestern University Feinberg School of Medicine
Director, Feinberg Cardiovascular Research Institute
Chief, Division of Medicine - Nephrology
Dr. Quaggin is the Charles H. Mayo Professor of Medicine and Chief of Nephology at Northwestern University. Her research program focuses on the genetic pathways required to establish and maintain microvascular beds.
Lee Rubin, Ph.D.
Professor, Department of Stem Cell and Regenerative Biology, Harvard University
Director of Translational Medicine, Harvard Stem Cell Institute
Dr. Rubin has worked in both industry and academia, and has drug discovery experience in both settings. He is currently a Professor at Harvard University, and Director of Translational Medicine at the Harvard Stem Cell Institute. His research interests focus on identifying therapeutics for orphan neural disorders.
Lois Smith, MD, PhD
Professor of Ophthalmology, Harvard Medical School, Boston Children’s Hospital
Dr. Smith is an ophthalmologist and clinician/scientist at Boston Children’s Hospital and Professor of Ophthalmology at Harvard Medical School. Her basic research work is in retinal neovascularization, both basic mechanism and treatment including diabetic retinopathy, retinopathy of prematurity, age-related macular degeneration and retinitis pigmentosa. She is the recipient of the Friedenwald award, the Alcon Research Institute award, the Silverman award, and the Bressler Prize.